CRL Annual Total Liabilities
$4.54 B
-$43.26 M-0.94%
30 December 2023
Summary:
As of January 21, 2025, CRL annual total liabilities is $4.54 billion, with the most recent change of -$43.26 million (-0.94%) on December 30, 2023. During the last 3 years, it has risen by +$1.19 billion (+35.52%). CRL annual total liabilities is now -0.94% below its all-time high of $4.58 billion, reached on December 31, 2022.CRL Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly Total Liabilities
$4.18 B
+$936.00 K+0.02%
28 September 2024
Summary:
As of January 21, 2025, CRL quarterly total liabilities is $4.18 billion, with the most recent change of +$936.00 thousand (+0.02%) on September 28, 2024. Over the past year, it has dropped by -$359.88 million (-7.93%). CRL quarterly total liabilities is now -13.65% below its all-time high of $4.84 billion, reached on June 25, 2022.CRL Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.9% | -7.9% |
| 3 y3 years | +35.5% | -7.9% |
| 5 y5 years | +80.2% | -7.9% |
CRL Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.9% | +2.3% | -13.7% | +0.0% |
| 5 y | 5-year | -0.9% | +49.9% | -13.7% | +38.0% |
| alltime | all time | -0.9% | +6805.3% | -13.7% | +1453.3% |
Charles River Laboratories International Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.18 B(+0.0%) |
| June 2024 | - | $4.18 B(-6.2%) |
| Mar 2024 | - | $4.45 B(-1.9%) |
| Dec 2023 | $4.54 B(-0.9%) | $4.54 B(+6.6%) |
| Sept 2023 | - | $4.26 B(-4.8%) |
| June 2023 | - | $4.47 B(-1.5%) |
| Mar 2023 | - | $4.54 B(-0.8%) |
| Dec 2022 | $4.58 B(+3.3%) | $4.58 B(-2.8%) |
| Sept 2022 | - | $4.71 B(-2.6%) |
| June 2022 | - | $4.84 B(+9.8%) |
| Mar 2022 | - | $4.40 B(-0.6%) |
| Dec 2021 | $4.43 B(+32.4%) | $4.43 B(-3.5%) |
| Sept 2021 | - | $4.59 B(+5.2%) |
| June 2021 | - | $4.37 B(+21.5%) |
| Mar 2021 | - | $3.59 B(+7.3%) |
| Dec 2020 | $3.35 B(+10.6%) | $3.35 B(+1.8%) |
| Sept 2020 | - | $3.29 B(-5.0%) |
| June 2020 | - | $3.46 B(-1.8%) |
| Mar 2020 | - | $3.52 B(+16.4%) |
| Dec 2019 | $3.03 B(+20.2%) | $3.03 B(+0.3%) |
| Sept 2019 | - | $3.02 B(-4.1%) |
| June 2019 | - | $3.15 B(+25.6%) |
| Mar 2019 | - | $2.51 B(-0.5%) |
| Dec 2018 | $2.52 B(+34.9%) | $2.52 B(-0.2%) |
| Sept 2018 | - | $2.52 B(-5.3%) |
| June 2018 | - | $2.66 B(+44.7%) |
| Mar 2018 | - | $1.84 B(-1.3%) |
| Dec 2017 | $1.87 B(+0.4%) | $1.87 B(+2.2%) |
| Sept 2017 | - | $1.83 B(+1.9%) |
| June 2017 | - | $1.79 B(-0.6%) |
| Mar 2017 | - | $1.80 B(-2.9%) |
| Dec 2016 | $1.86 B(+42.6%) | $1.86 B(+3.1%) |
| Sept 2016 | - | $1.80 B(-5.2%) |
| June 2016 | - | $1.90 B(+47.3%) |
| Mar 2016 | - | $1.29 B(-1.0%) |
| Dec 2015 | $1.30 B(+11.7%) | $1.30 B(+0.5%) |
| Sept 2015 | - | $1.30 B(+12.8%) |
| June 2015 | - | $1.15 B(-0.0%) |
| Mar 2015 | - | $1.15 B(-1.4%) |
| Dec 2014 | $1.17 B(+20.5%) | $1.17 B(+1.9%) |
| Sept 2014 | - | $1.14 B(-1.8%) |
| June 2014 | - | $1.16 B(+25.0%) |
| Mar 2014 | - | $931.50 M(-3.8%) |
| Dec 2013 | $968.10 M(-1.5%) | $968.10 M(-0.2%) |
| Sept 2013 | - | $969.74 M(+1.1%) |
| June 2013 | - | $959.21 M(-0.5%) |
| Mar 2013 | - | $963.94 M(-2.0%) |
| Dec 2012 | $983.14 M | $983.14 M(+1.6%) |
| Sept 2012 | - | $967.67 M(-1.4%) |
| June 2012 | - | $981.22 M(-2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $1.00 B(-2.9%) |
| Dec 2011 | $1.03 B(-1.3%) | $1.03 B(-1.2%) |
| Sept 2011 | - | $1.04 B(-6.4%) |
| June 2011 | - | $1.11 B(-5.5%) |
| Mar 2011 | - | $1.18 B(+13.0%) |
| Dec 2010 | $1.04 B(+25.8%) | $1.04 B(+0.2%) |
| Sept 2010 | - | $1.04 B(+36.6%) |
| June 2010 | - | $762.62 M(-5.1%) |
| Mar 2010 | - | $803.18 M(-3.3%) |
| Dec 2009 | $830.27 M(-13.6%) | $830.27 M(-1.4%) |
| Sept 2009 | - | $842.36 M(-3.3%) |
| June 2009 | - | $870.66 M(+0.1%) |
| Mar 2009 | - | $869.55 M(-9.5%) |
| Dec 2008 | $960.47 M(+2.0%) | $960.47 M(+1.2%) |
| Sept 2008 | - | $948.81 M(+0.7%) |
| June 2008 | - | $942.01 M(+1.2%) |
| Mar 2008 | - | $931.23 M(-1.1%) |
| Dec 2007 | $941.57 M(-1.2%) | $941.57 M(+1.2%) |
| Sept 2007 | - | $930.21 M(-0.1%) |
| June 2007 | - | $930.79 M(+0.8%) |
| Mar 2007 | - | $923.76 M(-3.1%) |
| Dec 2006 | $953.11 M(+35.9%) | $953.11 M(+1.3%) |
| Sept 2006 | - | $940.54 M(-2.8%) |
| June 2006 | - | $967.29 M(+45.4%) |
| Mar 2006 | - | $665.13 M(-5.2%) |
| Dec 2005 | $701.48 M(-38.7%) | $701.48 M(-11.7%) |
| Sept 2005 | - | $794.11 M(-1.6%) |
| June 2005 | - | $807.13 M(-26.6%) |
| Mar 2005 | - | $1.10 B(-3.9%) |
| Dec 2004 | $1.14 B(+252.4%) | $1.14 B(+230.0%) |
| Sept 2004 | - | $346.81 M(+3.9%) |
| June 2004 | - | $333.84 M(+3.5%) |
| Mar 2004 | - | $322.44 M(-0.7%) |
| Dec 2003 | $324.75 M(-0.2%) | $324.75 M(+0.3%) |
| Sept 2003 | - | $323.67 M(+2.3%) |
| June 2003 | - | $316.28 M(-0.3%) |
| Mar 2003 | - | $317.10 M(-2.6%) |
| Dec 2002 | $325.40 M(+21.0%) | $325.40 M(+6.2%) |
| Sept 2002 | - | $306.53 M(-0.1%) |
| June 2002 | - | $306.96 M(-15.6%) |
| Mar 2002 | - | $363.85 M(+35.3%) |
| Dec 2001 | $268.86 M(-4.1%) | $268.86 M(-8.7%) |
| Sept 2001 | - | $294.41 M(-0.6%) |
| June 2001 | - | $296.12 M(-14.0%) |
| Mar 2001 | - | $344.28 M(+22.8%) |
| Dec 2000 | $280.35 M(-40.7%) | $280.35 M(-0.7%) |
| Sept 2000 | - | $282.41 M(-42.7%) |
| June 2000 | - | $493.09 M(-1.1%) |
| Mar 2000 | - | $498.62 M |
| Dec 1999 | $472.89 M(+619.9%) | - |
| Dec 1998 | $65.69 M | - |
FAQ
- What is Charles River Laboratories International annual total liabilities?
- What is the all time high annual total liabilities for Charles River Laboratories International?
- What is Charles River Laboratories International annual total liabilities year-on-year change?
- What is Charles River Laboratories International quarterly total liabilities?
- What is the all time high quarterly total liabilities for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly total liabilities year-on-year change?
What is Charles River Laboratories International annual total liabilities?
The current annual total liabilities of CRL is $4.54 B
What is the all time high annual total liabilities for Charles River Laboratories International?
Charles River Laboratories International all-time high annual total liabilities is $4.58 B
What is Charles River Laboratories International annual total liabilities year-on-year change?
Over the past year, CRL annual total liabilities has changed by -$43.26 M (-0.94%)
What is Charles River Laboratories International quarterly total liabilities?
The current quarterly total liabilities of CRL is $4.18 B
What is the all time high quarterly total liabilities for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly total liabilities is $4.84 B
What is Charles River Laboratories International quarterly total liabilities year-on-year change?
Over the past year, CRL quarterly total liabilities has changed by -$359.88 M (-7.93%)